Monkeypox Testing Market Size

Monkeypox Testing Market Size

Monkeypox testing market size was valued at around USD 1.7 billion in 2023 and is estimated to grow at 4.5% CAGR from 2024 to 2032. Monkeypox testing refers to the diagnostic processes used to detect the presence of the monkeypox virus in an individual. Monkeypox is a viral zoonotic disease that is similar to smallpox, though generally less severe. Samples are collected from skin lesions, including swabs from the surface of the lesion or fluids from the vesicles and pustules. In some cases, throat swabs, blood, urine, or other bodily fluids may also be used.

The rising advancements in diagnostic research is a significant driver for the monkeypox testing market. For instance, according to the National Institutes of Health, in 2023, nucleic acid testing such as real-time PCR. It is considered the gold standard for diagnosing monkeypox, offering high sensitivity and specificity. Several real-time PCR assays have been developed for different targets in the monkeypox virus genome, providing a reliable means of detection.
 

Furthermore, increasing adoption of nucleic acid amplification testing, advancement in vaccines, increasing demand for self-testing, surging utilization of PCR technologies, government initiatives and funding, and increasing education & awareness, are the promoting factors advancing the growth of the market.